{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:10:05Z","timestamp":1774408205516,"version":"3.50.1"},"reference-count":28,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T00:00:00Z","timestamp":1621123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Prednisolone has been recommended rather than hydrocortisone for glucocorticoid replacement in adrenal insufficiency due its longer duration of action and lower cost.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine mortality rates with prednisolone versus hydrocortisone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this observational study, we used data extracted from a UK primary care database (Clinical Practice Research Datalink) to measure the relative mortality of patients with primary and secondary adrenal insufficiency, who were treated with either prednisolone or hydrocortisone, and control individuals who were individually matched for age, sex, period, and place of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>As expected, mortality in adrenal insufficiency irrespective of cause was increased, based on 5478 patients (4228 on hydrocortisone; 1250 on prednisolone) and 54 314 controls (41 934 and 12 380, respectively). Overall, the adjusted hazard ratio (HR) was similar with the 2 treatments (prednisolone, 1.76 [95% CI, 1.54-2.01] vs hydrocortisone 1.69 [1.57-1.82]; P = 0.65). This was also the case for secondary adrenal insufficiency. In primary disease (1405 on hydrocortisone vs 137 on prednisolone; 13 965 and 1347 controls, respectively), prednisolone users were older, more likely to have another autoimmune disease and malignancy, and less likely to have mineralocorticoid replacement. Nevertheless, after adjustment, the HR for prednisolone-treated patients remained higher than for those taking hydrocortisone (2.92 [2.19-3.91] vs 1.90 [1.66-2.16]; P = 0.0020).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In primary but not in secondary adrenal insufficiency, mortality was higher with prednisolone. The study was large, but the number of prednisolone-treated patients was small, and they had greater risk factors. Nonetheless, the increased mortality associated with prednisolone persisted despite statistical adjustment. Further evidence is needed regarding the long-term safety of prednisolone as routine replacement.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab347","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T19:59:10Z","timestamp":1621195150000},"page":"2242-2251","source":"Crossref","is-referenced-by-count":8,"title":["Mortality Risk in Patients With Adrenal Insufficiency Using Prednisolone or Hydrocortisone: A Retrospective Cohort Study"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4392-269X","authenticated-orcid":false,"given":"Kanchana","family":"Ngaosuwan","sequence":"first","affiliation":[{"name":"Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College, London, UK"},{"name":"Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond G","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian F","family":"Godsland","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, St. Mary\u2019s Hospital, Imperial College; NHS trust, London,UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Majeed","sequence":"additional","affiliation":[{"name":"School of Public Health, Imperial College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-4869","authenticated-orcid":false,"given":"Jennifer K","family":"Quint","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Oliver","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, St. Mary\u2019s Hospital, Imperial College; NHS trust, London,UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2021,5,16]]},"reference":[{"key":"2021122204430992900_CIT0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6823-12-8","article-title":"Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey","volume":"12","author":"Forss","year":"2012","journal-title":"BMC Endocr Disord."},{"issue":"3","key":"2021122204430992900_CIT0002","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/cen.13267","article-title":"Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR","volume":"86","author":"Murray","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021122204430992900_CIT0003","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021122204430992900_CIT0004","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122204430992900_CIT0005","doi-asserted-by":"crossref","first-page":"g4843","DOI":"10.1136\/bmj.g4843","article-title":"Glucocorticoid replacement","volume":"349","author":"Amin","year":"2014","journal-title":"BMJ."},{"issue":"1","key":"2021122204430992900_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-16-0081","article-title":"Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency","volume":"6","author":"Quinkler","year":"2017","journal-title":"Endocr Connect."},{"issue":"6","key":"2021122204430992900_CIT0007","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EC-18-0160","article-title":"Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency","volume":"7","author":"Frey","year":"2018","journal-title":"Endocr Connect."},{"issue":"8","key":"2021122204430992900_CIT0008","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1530\/EC-17-0257","article-title":"Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement","volume":"6","author":"Smith","year":"2017","journal-title":"Endocr Connect."},{"issue":"1","key":"2021122204430992900_CIT0009","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1530\/EC-18-0418","article-title":"Glucocorticoid management of adrenal insufficiency in the United Kingdom: assessment using real-world data","volume":"8","author":"Iqbal","year":"2019","journal-title":"Endocr Connect."},{"key":"2021122204430992900_CIT0010","article-title":"Increased mortality risk in patients with primary and secondary adrenal insufficiency","author":"Ngaosuwan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021122204430992900_CIT0011","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol."},{"key":"2021122204430992900_CIT0012","article-title":"Data from: Supplementary: Mortality in prednisolone vs. hydrocortisone users","author":"Ngaosuwan"},{"issue":"9254","key":"2021122204430992900_CIT0013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet."},{"issue":"12","key":"2021122204430992900_CIT0014","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122204430992900_CIT0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021122204430992900_CIT0016","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122204430992900_CIT0017","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1210\/clinem\/dgab063","article-title":"Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities","volume":"106","author":"Ngaosuwan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122204430992900_CIT0018","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/B978-0-323-29738-7.00015-0","article-title":"The Adrenal Cortex.","volume-title":"Williams Textbook of Endocrinology","author":"Stewart","year":"2016","edition":"13th ed"},{"issue":"5","key":"2021122204430992900_CIT0019","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00228-004-0738-z","article-title":"Pharmacokinetic\/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men","volume":"60","author":"Dubois","year":"2004","journal-title":"Eur J Clin Pharmacol."},{"issue":"9","key":"2021122204430992900_CIT0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ncb1922","article-title":"Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription","volume":"11","author":"Stavreva","year":"2009","journal-title":"Nat Cell Biol."},{"issue":"3","key":"2021122204430992900_CIT0021","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-09-0884","article-title":"Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies","volume":"162","author":"Hahner","year":"2010","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2021122204430992900_CIT0022","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1210\/jc.2002-020970","article-title":"11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids","volume":"87","author":"Diederich","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122204430992900_CIT0023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.0.1510397","article-title":"Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties","volume":"151","author":"Grossmann","year":"2004","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122204430992900_CIT0024","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-08-0578","article-title":"Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens","volume":"159","author":"Bleicken","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021122204430992900_CIT0025","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1016\/0303-7207(92)90091-J","article-title":"The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited","volume":"90","author":"Munck","year":"1992","journal-title":"Mol Cell Endocrinol."},{"issue":"3","key":"2021122204430992900_CIT0026","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology. Adrenal crisis","volume":"172","author":"Allolio","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2021122204430992900_CIT0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2021122204430992900_CIT0028","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison\u2019s disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab347\/38488214\/dgab347.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/8\/2242\/41847988\/dgab347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/8\/2242\/41847988\/dgab347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T04:47:37Z","timestamp":1640148457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/8\/2242\/6276537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,16]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,5,16]]},"published-print":{"date-parts":[[2021,7,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab347","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,5,16]]}}}